The prevalence of Age Related Macular Degeneration (AMD) is rapidly increasing with 20 million Americans projected to be diagnosed by 2020.  AMD Awareness Week unites worldwide organization in a common goal.

The global cost of macula disease, according to a recent report by AMD Alliance International (AMDAI), is estimated at $343 billion. This underscores the need for swift actions to raise awareness of prevention and treatment options.

This year’s AMD Week runs from September 18-26. Prevent Blindness America, along with AMDAI and leading eye-care organizations from 25 countries have issued a call to action to doctors, patients and caregivers through a public awareness campaign titled Don’t Surrender to AMD.

Don Curran, AMDAI’s chairman made this important statement when launching this campaign, “This is a promising time for patients as preventative measures and effective, timely treatments have the ability to alter the disease tremendously. But, macular disease is only as preventable and manageable as people are knowledgeable.”

Knowing the facts can significantly improve a person’s chances of maintaining healthy vision and a better quality of life.

Losing vision has devastating consequences to an individual’s daily life and those affected by the disease too often suffer from severe depression and loss of independence.

However, those at-risk and diagnosed patients can take steps to reduce needless sight loss.  Evidence continues to grow that links nutritional intake (including indication-specific supplementation) with eye disease prevention and disease control. And, effective clinically-approved treatments are available for wet AMD.

In addition, the Biosyntrx founders, staff and scientific advisory board strongly recommend low vision rehabilitation and support services information for those diagnosed with AMD. This information helps to lower the anxiety associated with the diagnoses, and when or if the services become necessary, they can significantly help patients live with macula disease and make the most of their vision.

“AMD is a disease that we can prevent and manage,” says Dr. Alan Cruess, Chairman of AMD Alliance International’s Scientific Advisory Panel. “We have the ability to save the sight of many Americans each year.”

Prevent Blindness America has increased public education efforts – which will span across print, radio, and digital media, including an interactive e-card– to inform the public of preventative measures and treatment options that are available in the fight against AMD.

Ellen Troyer, MT MA

Biosyntrx CEO / Chief Research Officer

Read more about AMD here